A multicenter, placebo controlled trial of continuous intravenous diltiazem infusion (IV DILT) for twenty-four hour rate control during atrial flutter/fibrillation (Af1/Afib)

✍ Scribed by Kenneth A Ellenbogen; Virgil C Dias; Vance J Plumb; J.Thomas Heywood; David M Mirvis; Liguat Zanan; Jan Christy-Bittel; Co-Investigators

• Book ID: 118414168
• Publisher: Elsevier Science
• Year: 1990
• Tongue: English
• Weight: 234 KB
• Volume: 15
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/0735-1097(90)91881-t